Magene Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 05-07-2024
- Paid Up Capital ₹ 2.10 M
as on 05-07-2024
- Company Age 22 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.44 Cr
as on 05-07-2024
- Satisfied Charges ₹ 3.44 Cr
as on 05-07-2024
- Revenue %
(FY 2020)
- Profit 68.56%
(FY 2020)
- Ebitda 68.56%
(FY 2020)
- Net Worth
- Total Assets
About Magene Life Sciences
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.10 M.
The company currently has active open charges totaling ₹3.44 Cr. The company has closed loans amounting to ₹3.44 Cr, as per Ministry of Corporate Affairs (MCA) records.
Anantha Chary and Surekha Madabhushini serve as directors at the Company.
- CIN/LLPIN
U24231TG2002PTC038939
- Company No.
038939
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 May 2002
- Date of AGM
27 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Magene Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anantha Chary  | Director | 13-May-2002 | Current |
| Surekha Madabhushini | Director | 04-Sep-2017 | Current |
Financial Performance and Corporate Structure Insights of Magene Life Sciences.
Magene Life Sciences Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 68.56% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Magene Life Sciences?
In 2020, Magene Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Magene Research FoundationActive 26 years 9 monthsAnantha Chary and Surekha Madabhushini are mutual person
- Concept Industries Private LimitedActive 31 years 5 months
Anantha Chary and Surekha Madabhushini are mutual person
- Charys Investments Private LimitedActive 36 years 1 month
Anantha Chary and Surekha Madabhushini are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Technology Development Board Creation Date: 02 Nov 2005 | ₹3.44 Cr | Open |
Technology Development Board Creation Date: 02 Nov 2005 | ₹3.44 Cr | Satisfied |
How Many Employees Work at Magene Life Sciences?
Unlock and access historical data on people associated with Magene Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Magene Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Magene Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
